GB9211677D0 - Peptide compounds - Google Patents

Peptide compounds

Info

Publication number
GB9211677D0
GB9211677D0 GB929211677A GB9211677A GB9211677D0 GB 9211677 D0 GB9211677 D0 GB 9211677D0 GB 929211677 A GB929211677 A GB 929211677A GB 9211677 A GB9211677 A GB 9211677A GB 9211677 D0 GB9211677 D0 GB 9211677D0
Authority
GB
United Kingdom
Prior art keywords
peptide compounds
peptide
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929211677A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nycomed Bioreg AS
Original Assignee
Nycomed Bioreg AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Bioreg AS filed Critical Nycomed Bioreg AS
Priority to GB929211677A priority Critical patent/GB9211677D0/en
Publication of GB9211677D0 publication Critical patent/GB9211677D0/en
Priority to AU43402/93A priority patent/AU4340293A/en
Priority to LTIP606A priority patent/LT3613B/en
Priority to JP6500361A priority patent/JPH08501065A/en
Priority to LVP-93-457A priority patent/LV10286B/en
Priority to PCT/GB1993/001170 priority patent/WO1993024522A1/en
Priority to CN93108405A priority patent/CN1085911A/en
Priority to EP93913275A priority patent/EP0647237A1/en
Priority to ZA933867A priority patent/ZA933867B/en
Priority to EE9400182A priority patent/EE9400182A/en
Priority to NO944668A priority patent/NO944668D0/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GB929211677A 1992-06-02 1992-06-02 Peptide compounds Pending GB9211677D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB929211677A GB9211677D0 (en) 1992-06-02 1992-06-02 Peptide compounds
ZA933867A ZA933867B (en) 1992-06-02 1993-06-02 Peptide compounds
LVP-93-457A LV10286B (en) 1992-06-02 1993-06-02 Peptide compounds
LTIP606A LT3613B (en) 1992-06-02 1993-06-02 Peptide compounds, method for the preparation and use thereof
JP6500361A JPH08501065A (en) 1992-06-02 1993-06-02 Peptide compounds
AU43402/93A AU4340293A (en) 1992-06-02 1993-06-02 Double chain peptide compounds having hemoregulatory activity
PCT/GB1993/001170 WO1993024522A1 (en) 1992-06-02 1993-06-02 Double chain peptide compounds having hemoregulatory activity
CN93108405A CN1085911A (en) 1992-06-02 1993-06-02 Peptide compounds
EP93913275A EP0647237A1 (en) 1992-06-02 1993-06-02 Double chain peptide compounds having hemoregulatory activity
EE9400182A EE9400182A (en) 1992-06-02 1994-11-16 Peptide compounds, their use, method of preparation and pharmaceutical composition
NO944668A NO944668D0 (en) 1992-06-02 1994-12-02 Double-chain peptide compounds with hemoregulatory activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929211677A GB9211677D0 (en) 1992-06-02 1992-06-02 Peptide compounds

Publications (1)

Publication Number Publication Date
GB9211677D0 true GB9211677D0 (en) 1992-07-15

Family

ID=10716410

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929211677A Pending GB9211677D0 (en) 1992-06-02 1992-06-02 Peptide compounds

Country Status (11)

Country Link
EP (1) EP0647237A1 (en)
JP (1) JPH08501065A (en)
CN (1) CN1085911A (en)
AU (1) AU4340293A (en)
EE (1) EE9400182A (en)
GB (1) GB9211677D0 (en)
LT (1) LT3613B (en)
LV (1) LV10286B (en)
NO (1) NO944668D0 (en)
WO (1) WO1993024522A1 (en)
ZA (1) ZA933867B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9324691D0 (en) * 1993-12-01 1994-01-19 Hafslund Nycomed As Peptide compounds
GB9425730D0 (en) * 1994-12-20 1995-02-22 Nycomed Pharma As Compounds
EP3352281B1 (en) * 2015-09-17 2021-08-11 Adeka Corporation Non-aqueous electrolyte solution and non-aqueous electrolyte secondary battery

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058512A (en) * 1975-04-28 1977-11-15 Ab Kabi Synthetic peptides having growth promoting activity
FI77875C (en) 1982-11-26 1989-05-10 Nyegaard & Co As FOERFARANDE FOER FRAMSTAELLNING AV NYA TERAPEUTISKT ANVAENDBARA PEPTIDER.
GB8626539D0 (en) 1986-11-06 1986-12-10 Nycomed As Peptide compounds
GB8821785D0 (en) 1988-09-16 1988-10-19 Nycomed As Peptide compounds
ZW11290A1 (en) * 1989-07-14 1990-10-31 Smithkline Beecham Corp Hemoregulatory peptides

Also Published As

Publication number Publication date
LV10286B (en) 1995-04-20
NO944668L (en) 1994-12-02
AU4340293A (en) 1993-12-30
EE9400182A (en) 1996-02-15
CN1085911A (en) 1994-04-27
LV10286A (en) 1994-10-20
LT3613B (en) 1995-12-27
JPH08501065A (en) 1996-02-06
NO944668D0 (en) 1994-12-02
LTIP606A (en) 1995-01-31
WO1993024522A1 (en) 1993-12-09
EP0647237A1 (en) 1995-04-12
ZA933867B (en) 1994-06-14

Similar Documents

Publication Publication Date Title
GB2269176B (en) Peptides
AU4715493A (en) Peptide compounds
AP9300508A0 (en) Compounds
GB9200245D0 (en) Compounds
GB9201755D0 (en) Compounds
GB9200210D0 (en) Compounds
GB9201694D0 (en) Compounds
GB9201693D0 (en) Compounds
GB9200209D0 (en) Compounds
GB9226065D0 (en) Peptides
GB9200566D0 (en) Compounds
GB9201751D0 (en) Compounds
GB9202792D0 (en) Compounds
GB9201692D0 (en) Compounds
ZA933867B (en) Peptide compounds
ZA931299B (en) Novel peptides
GB9211668D0 (en) Peptide compounds
GB9324691D0 (en) Peptide compounds
ZA933868B (en) Peptide compounds
GB9211676D0 (en) Peptide compounds
GB9211675D0 (en) Peptide compounds
GB9226074D0 (en) Peptide
GB9315987D0 (en) Peptide compounds
GB9320875D0 (en) Peptide compounds
GB9312867D0 (en) Peptide compounds